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Abnormal electrophysiological motor responses in Huntington's disease:
Evidence of premanifest compensation
Abstract
Background: Huntington's disease (HD) causes progressive motor dysfunction through characteristic
atrophy. Changes to neural structure begin in premanifest stages yet individuals are able to maintain a high
degree of function, suggesting involvement of supportive processing during motor performance.
Electroencephalography (EEG) enables the investigation of subtle impairments at the neuronal level, and
possible compensatory strategies, by examining differential activation patterns. We aimed to use EEG to
investigate neural motor processing (via the Readiness Potential; RP), premotor processing and sensorimotor
integration (Contingent Negative Variation; CNV) during simple motor performance in HD. Methods: We
assessed neural activity associated with motor preparation and processing in 20 premanifest (pre-HD), 14
symptomatic HD (symp-HD), and 17 healthy controls. Participants performed sequential tapping within two
experimental paradigms (simple tapping; Go/No-Go). RP and CNV potentials were calculated separately for
each group. Results: Motor components and behavioural measures did not distinguish pre-HD from controls.
Compared to controls and pre-HD, symp-HD demonstrated significantly reduced relative amplitude and
latency of the RP, whereas controls and pre-HD did not differ. However, early CNV was found to significantly
differ between control and pre-HD groups, due to enhanced early CNV in pre-HD. Conclusions: For the first
time, we provide evidence of atypical activation during preparatory processing in pre-HD. The increased
activation during this early stage of the disease may reflect ancillary processing in the form of recruitment of
additional neural resources for adequate motor preparation, despite atrophic disruption to structure and
circuitry. We propose an early adaptive compensation mechanism in pre-HD during motor preparation.
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Huntington's disease (HD) causes progressive motor dysfunction through characteristic
atrophy. Changes to neural structure begin in premanifest stages yet individuals are able to
maintain a high degree of function, suggesting involvement of supportive processing during
motor performance. Electroencephalography (EEG) enables the investigation of subtle
impairments at the neuronal level, and possible compensatory strategies, by examining dif-
ferential activation patterns. We aimed to use EEG to investigate neural motor processing
(via the Readiness Potential; RP), premotor processing and sensorimotor integration (Con-
tingent Negative Variation; CNV) during simple motor performance in HD.
Methods
We assessed neural activity associated with motor preparation and processing in 20 pre-
manifest (pre-HD), 14 symptomatic HD (symp-HD), and 17 healthy controls. Participants
performed sequential tapping within two experimental paradigms (simple tapping; Go/No-
Go). RP and CNV potentials were calculated separately for each group.
Results
Motor components and behavioural measures did not distinguish pre-HD from controls.
Compared to controls and pre-HD, symp-HD demonstrated significantly reduced relative
amplitude and latency of the RP, whereas controls and pre-HD did not differ. However,
early CNV was found to significantly differ between control and pre-HD groups, due to
enhanced early CNV in pre-HD.
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Conclusions
For the first time, we provide evidence of atypical activation during preparatory processing
in pre-HD. The increased activation during this early stage of the disease may reflect ancil-
lary processing in the form of recruitment of additional neural resources for adequate motor
preparation, despite atrophic disruption to structure and circuitry. We propose an early
adaptive compensation mechanism in pre-HD during motor preparation.
Introduction
Huntington’s disease (HD), a monogenetic, neurodegenerative disease, causes progressive
motor, cognitive, and behavioural impairment [1]. Symptom onset occurs in the 4th decade of
life; however, there is robust evidence of striatal and cortical atrophy up to 20 years prior to
diagnosis [2–8]. Despite early neuropathological changes, individuals retain normal functions.
Subtle cognitive and motor changes (e.g., tapping precision) have been shown to commence up
to a decade prior to onset but progress at a slower rate than atrophy [8–9]. Specifically, observ-
able motor impairment has been highlighted during more complex tasks,[10] which may
implicate recruitment of ancillary regions to offset dysfunction in motor control. There is a
growing interest in understanding the underlying brain mechanisms that enable individuals to
function normally in the context of early degenerative processes. Structural degradation may
be mitigated by neural compensation, which could support optimal performance during early
stages of HD [3–5, 11–13]. Electroencephalography (EEG) provides a means of investigating
functional impairment at the neuronal (ensemble) level, and offers an important opportunity
to further investigate the mechanisms driving compensation [14]. In this context, EEG mea-
sures may also offer a new avenue for functional biomarker discovery where postsynaptic neu-
ral activity could be evaluated during early drug development. In this study, we focus on the
temporal properties of neural ensemble activity characterising various elements of motor
control.
Neuropathological changes, such as striatal volume loss, may have minimal functional con-
sequences due to efferent and reciprocal connections between brain regions [15]. That is, net-
works requiring coordination from multiple groups of neurons may maintain function despite
localised damage. Previous functional magnetic resonance imaging (fMRI) studies have identi-
fied premanifest changes to neural networks, including reduced functional connectivity in cor-
tico-striatal networks implicated in motor control [5, 16–19]. Recently, decreased synchrony of
sensorimotor networks was found to correlate with motor imprecision during speeded self-tap-
ping, and to precede cognitive impairment in dorsal networks [16]. This suggests that an
impairment of motor circuitry may represent an early signature of disease progression. Cortical
shifts, such as concurrent brain activation, may enable premanifest individuals to compensate
effectively for early deficits in motor control, while still cognitively intact [11].
Investigations of functional connectivity in motor control support recruitment of ancillary
circuity to supplement motor performance. For example, in symptomatic individuals (symp-
HD), reduced primary motor activation has been accompanied by parietal overactivation [20–
22] and in presymptomatic individuals (pre-HD) by excessive thalamo-cortical activation [23].
In particular, Klöppel and colleagues [13] identified increased compensation in pre-HD indi-
viduals, involving flexible recruitment of premotor and parietal areas dependent on the pace
and complexity of motor sequences. In studies with pre-HD, no between-group differences
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have been identified in task performance, further suggesting the motor system is adept at re-
organising itself according to task demands [13].
Elicited from EEG, movement-related potentials (MRPs) provide a measure of cortical
activity associated with movement preparation and execution [24]. The Readiness Potential
(RP) represents movement preparation and is decreased in amplitude in movement disorders
such as Parkinson’s disease [24–25]. Reduced RP components have also been previously
reported in symp-HD, compared with controls [12, 26–27]; however, in pre-HD no RP differ-
ences have been detected despite increased inhibition in the hemisphere ipsilateral to dominant
hand which may reflect compensatory mediation by GABAergic transmission [11–12]. In pre-
motor activation, the Contingent Negative Variation (CNV) has also been found to be signifi-
cantly reduced in symp-HD [28]; to date no CNV studies have been conducted in pre-HD.
In this investigation, we aimed to evaluate neural motor mechanisms in both pre-HD and
symp-HD, compared with healthy controls, using electrophysiological measures (i.e., RP and
CNV). In doing so, we aimed to evaluate the neural compensatory hypothesis first proposed by




Forty-four participants were recruited for this study, consisting of 14 HD individuals (11
males; symp-HD), 20 prodromal individuals (12 males; pre-HD), and 17 healthy controls (9
males), age-matched to the pre-HD group. The EEG recording session entailed two tasks and
participants with response amplitudes greater than -25 μV or excessive muscular artifacts were
excluded. In Task 1 (cued and self-paced tapping), 7 participants were excluded, 3 pre-HD (3
males), and 4 symp-HD (3 males); in Task 2 (sensorimotor integration), 3 participants were
excluded including 1 pre-HD (1 male), and 2 symp-HD (1 male). Participant demographics
and clinical data for the overall sample are provided in Table 1. Pre-HD and symp-HD partici-
pants underwent genetic testing to confirm gene status and estimate CAG repeat length. Both
HD groups of were assessed by a neurologist (A.C.) and underwent the Unified Huntington’s
Disease Rating Scale (UHDRS)[29] as a measure of motor severity. HD individuals with an
UHDRS TMS (Total Motor Score) of< 5 were included in the pre-HD group and those with
scores of> 5 in the symp-HD group (consistent with TRACK-HD)[6]. Formal ethics approval
was granted by Monash University, with written informed consent was obtained from all par-
ticipants. All clinical investigation was conducted according to the principles expressed in the
Declaration of Helsinki.
Neurocognitive testing included a speeded tapping task to assess motor performance [30],
Trails B to assess executive functioning [31], and the Hopkins Verbal Learning Task (HVLT)
to assess memory functioning [32]. Depressive symptoms were assessed using the Beck Depres-
sion Inventory-II (BDI-II)[33].
Procedures
EEG tasks. As part of a larger study, participants completed a series of electrophysiological
tasks. In order of presentation, these consisted of an EOG calibration task [34], a cued and self-
paced tapping task (Task 1), sensorimotor integration task (Go/No-Go paradigm; Task 2),
working memory rehearsal, auditory and cognitive processing (oddball paradigm), face emo-
tion processing, sustained attention task, with practice trials immediately prior to each task.
Only the tapping and sensorimotor integration tasks are reported here.
Motor Compensation in Huntington’s Disease
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Cued and Self-Paced Tapping (Task 1). Participants performed a sequential tapping task
on a response pad (Version 4.0; Compumedics, Neuroscan, TX, USA) using their right index
finger. They were required to alternate between two buttons (left and right), at a rate of one
every four seconds. The task comprised two Conditions (cued and self-paced). In the cued
Condition, accompanying visual cues were provided by a square appearing on either the left or
right of the screen. The cues were presented for 1000 ms, once every four seconds, for a period
of 24 s. Participants were instructed to respond on the same side as the indicated cue as quickly
as possible. In the self-paced Condition, participants continued to press alternating buttons at
the same rate in the absence of cues. The two Conditions alternated for a total of 8 minutes,
resulting in a total of 60-cued and 60 self-paced button presses in the task.
Sensorimotor Integration (Task 2). Participants were presented with a 500 ms blue light
flash (S1), followed 2.5 s later (fixed interval) by an ‘X’ or ‘Y’ visual cue (S2). S2-No-Go (Y)
cues remained on screen for 1.9 s; S2-Go (X) cues remained on screen until a response. The ‘X’
stimulus was designated as a Go stimulus, requiring a motor response; the ‘Y’ stimulus was des-
ignated as a No-Go stimulus, indicating response should be withheld. Presentation of ‘X’ and
‘Y’ cues was varied randomly between the left and right sides of the screen, with location (of
the ‘X’) indicating a corresponding button press of the ipsilateral key as quickly as possible
using the right index finger. A total of 90 trials were performed, with the No-Go stimulus
occurring in 20% of trials. The inter-trial intervals were randomly varied between 2500 and
4000 ms.
Table 1. Demographic data for participants included in analyses of RP and CNV task. Standard deviations (SD) provided in parentheses.
Controls(n = 17) Pre-HD(n = 20) Symp-HD(n = 14)
Gender (M:F) 9:8 12:8 11:3
Age 41.00 (11.32) 41.11 (10.88) 58.64 (10.31)a**b**
Education (yrs) 12.59 (2.10) 12.36 (2.31) 11.14 (2.71)
CAG repeat length - 41.53 (2.50) 42.21 (1.97)
CAG-index - 238.08 (101.88) 346.08 (68.26)b**
Probability of Diagnosis in 5 years - 0.17 (0.20) -
Illness Duration - - 4.07 (3.83)
DBS - 239.39 (100.66) 387.82 (111.54)
UHDRS - 0.63 (1.16) 22.29 (10.62)
IQ estimate 104.88 (27.76) 112.92 (6.03) 109.70 (7.03)
BDI-II 2.12 (3.02) 7.16 (9.98) 8.14 (8.38)
Trails B 61.30 (16.33) 67.73 (21.60) 166.79 (77.63)a**b**
Speeded Tapping 186.25 (55.32) 218.61 (25.32) 362.45 (114.51)a**b**
HVLT Total Recall 28.24 (3.87) 25.16 (4.89) 15.86 (7.01)a**b**
HVLT Delayed Recall 10.06 (1.89) 8.89 (2.13) 5.50 (3.23)a**b**
HVLT % Retention 88.46 (15.37) 88.78 (10.80) 78.17 (33.03)
HVLT Recognition Discrimination Index 11.53 (1.46) 9.89 (1.41)a* 7.93 (2.43)a**b*
CAG, cytosine-adenine-guanine; CAG-index, [CAGn(# of CAG repeats)– 35.5]multiplied by age; probability of onset in 5-years; DBS, Disease Burden
Score (CAG-35.5)*age; UHDRS, motor subscale score, Unified Huntington’s Disease Rating Scale (pre-HD, UHDRS <5; symp-HD, UHDRS 5); IQ
(NART: National Adult Reading Test 2nd Edition); BDI-II, Beck Depression Inventory—second edition; Trails B, Trail Making Test Two-Target-Switch;
HVLT, Hopkins Verbal Learning Test. Independent samples t-test for differences between groups;
* p < .05,
** p < .01;
a significantly different from controls,
b significantly different from pre-HD.
doi:10.1371/journal.pone.0138563.t001
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Electrophysiological Recording. Presentation of stimuli and recording of behavioural
responses were controlled by Stim2 (Version 4.0; Compumedics, Neuroscan, TX, USA). EEG
data were recorded and processed using Scan 4.1 (Compumedics, Neuroscan, TX) software. A
40-channel Lycra EEG cap with embedded tin surface electrodes was used, following the inter-
national 10/20 system. The EEG was referenced to a point midway between Cz and Pz, with a
ground electrode located midway between Fz and FPz. Impedances were below 10 kO for all
electrodes at the start of the recording. Eye movements (EOG) were measured for subsequent
EOG correction, with electrodes placed above and below the left eye, and on the outer canthus
of each eye. EEG and EOG signals were amplified using a NuAmps 40-channel DC amplifier
(Compumedics, Neuroscan, TX) with a digital bandpass filter at 0.15–100 Hz, and sampled at
1000 Hz.
Data Analysis
Electrophysiological Data. Readiness Potential (RP)—Cued and Self-Paced Tapping
(Task 1). Offline RP data were EOG-corrected [34], and bandpass filtered using a 20 Hz (48
dB roll-off) to 100 Hz (12 dB roll-off) zero phase shift filter. The epoch segment comprised the
period -2998 ms before to 1000 ms following movement execution (button press), with subse-
quent baseline correction (relative to -2500 to -2000 ms), artifact rejection procedures
(±150μV; excluding EOG channels), and further removal of visually determined contaminated
trials. Epochs were then averaged separately for each electrode site and Condition (i.e., cued
and self-paced). As RP amplitude was maximal at Cz, analysis was restricted to this site. Partic-
ipants with less than 15 epochs for a Condition were excluded from further analysis. The rela-
tive amplitude and latency of the RP respectively was computed using peak-to-peak values
comprised of the difference between the negative peak occurring at -50 to 100 ms, and the posi-
tive peak 100 to 300 ms post response. Owing to inter-individual variability in activation, peak-
to-peak values were used to provide a more accurate reflection of elevation from baseline dur-
ing the RP than peak amplitudes, which may be affected by a range of factors including motiva-
tion during the task.
Contingent Negative Variation—Sensorimotor Integration (Task 2). CNV data were
EOG-corrected [34], and bandpass filtered using a 0.03 to 35 Hz (24 dB roll-off) zero phase
shift filter consistent with previous literature.[28] Data were epoched to the period of -3500 to
1000 ms relative to S2 (Go-No-Go) cue presentation and baseline corrected (relative to -3500
to -3000 ms). Artifact rejection procedures were automated (±150μV; excluding EOG chan-
nels), with additional rejection of contaminated trials based on visual inspection. Epochs were
averaged separately for each electrode site; both Go and No-Go trials were included in the
grand average. CNV Amplitudes were measured as maximum amplitudes obtained in the peri-
ods 550–750 ms following the presentation of S1 (early CNV; eCNV), and in the 200 ms prior
to the onset of S2 respectively (late CNV; lCNV)[28]. Peak-to-peak values were used to better
account for inter-individual variation and degree of activation across the entire CNV profile
(early and late peaks), rather than amplitude values. Values were calculated using the difference
between the maximum amplitude obtained during the eCNV, and that of the lCNV.
Statistical Analysis. For each task separately, each behavioural measure (reaction time,
inter-tap intervals, inter-tap interval variability), RP (amplitude, latency) and CNV component
(early, late, difference) was examined separately (dependent variable) using a mixed design
ANCOVA, with group (symp-HD; pre-HD; controls) the between-subjects factor and age a
covariate. For Task 1, RP analyses contained a within-subjects factor Condition (cued; self-
paced). For Task 2, early and late CNV values were initially taken at Cz.Subsequent exploratory
analysis of sites Fz and Pz was based on prior studies [24], and was included to investigate
Motor Compensation in Huntington’s Disease
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possible abnormal activation in these sites [13, 20–23]. Bonferroni adjustments were used to
control for multiple comparisons in all post-hoc testing. Pearson partial correlations (control-
ling for age) were used to examine the relationship between electrophysiological variables and
clinical measures of disease progression for pre-HD and symp-HD groups.
Results
Behavioural
Behavioural results for Task 1 and Task 2 are presented in Tables 2 and 3 respectively. For
Task 1 (cued and self-paced tapping), there was a significant main effect of Group for tapping
variability (F (2, 40) = 6.691, p = .003), with symp-HD more variable than control (p = .003)
and pre-HD (p = .008) groups. For Task 2 (sensorimotor integration) there was a significant
main effect of Group for reaction time (F = 11.360, p< .001), with symp-HD (1306.66 ± 324)
slower than controls (750.97 ± 203, p< .001) and pre-HD (779.11 ± 243.62, p< .001) groups.
There was no difference in Go/No-Go errors between groups, with all groups responding accu-
rately to each condition.
Electrophysiological
Readiness Potential (RP)—Cued and Self-Paced Tapping (Task 1). Table 2 displays
peak and relative amplitude values and relative latency at Cz; grand average waveforms of the
RP are shown in Fig 1. There was a significant main effect of Group for RP relative amplitude
(F (2, 40) = 10.52, p< .001), with larger relative amplitudes for controls (-9.99 ± 4.58, p<
.001) and pre-HD (-7.97 ± 3.17, p = .009) compared to symp-HD (-3.51 ± 2.30). There was also
a significant main effect of Group for relative latency (F (2, 40) = 3.35, p = .045); post-hoc anal-
yses only identified a trend-level reduction in RP latencies for controls (-160.88 ± 61.35) com-
pared to symp-HD (-209.56 ± 72.40, p = .052).
Contingent Negative Variation—Sensorimotor Integration (Task 2). Peak and mean
amplitudes of the eCNV and lCNV at Fz, Cz, and Pz for each group separately are shown in
Table 3. CNV values at Cz constituted the main analysis, with values at Fz and Pz constituting
an exploratory analysis. Grand average waveforms and exploratory topographic maps are pro-
vided in Fig 2. Typical grand mean distribution is observed with CNVs maximal at central
scalp sites (Cz), and beginning approximately 1500 ms prior to presentation of stimulus 2 (S2).
Exploratory topographic maps suggest lateralisation of the early and late CNV in pre-HD.
There was a significant main effect of Group for eCNV peak amplitude (F (2, 44) = 4.697, p
= .014), with symp-HD (-0.67 ± 3.65) amplitudes reduced relative to pre-HD (-7.23 ± 6.37, p =
.026). No group differences were found for lCNV. However, examination of relative amplitude
(early/late peak amplitude difference) revealed a significant main effect of Group (F = 4.190, p
= .022), in which pre-HD relative amplitude (0.51 ± 5.47) was significantly (p = .018) smaller
than that of controls (5.15 ± 4.04).
For the eCNV, peak amplitude at Pz was significantly different across groups (F (2, 44) =
3.637, p = .035), with the difference between symp-HD (-0.16 ± 4.81) and pre-HD approaching
significance (-5.08 ± 4.76, p = .056). In the lCNV, peak amplitude at Fz was significantly differ-
ent among the groups (F = 4.298, p = .020); symp-HD (-0.03 ± 4.9) had significantly smaller
amplitude than controls (-5.49 ± 4.94, p = .028) and pre-HD (-5.35 ± 3.42, p = .030). At Pz,
peak amplitude was significantly different across groups (F = 3.738, p = .032); symp-HD were
significantly smaller than pre-HD (-1.80 ± 5.21 and -6.99 ± 5.49 respectively, p = .040).
Correlational Analyses—Sensorimotor Integration (Task 2). For pre-HD, lCNV peak
amplitude at Cz correlated with CAG repeats (.526, p = .025). For the symp-HD group, Pz
lCNV peak amplitude correlated with CAG repeats (.636, p = .026), and DBS (.625, p = .030).
Motor Compensation in Huntington’s Disease
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Peak amplitude for both Fz eCNV (.608, p = .036) and lCNV (.645, p = .021) correlated with
UHDRS motor score.
Conclusions
This study investigated neural motor and premotor processing during a simple motor task in
Huntington’s disease. Symp-HD were significantly differentiated by behavioural measures
(slower, more variable taps across tasks) and electrophysiological activity in both motor
(smaller relative RP amplitudes) and premotor components (smaller early and late CNV peaks
at Cz, and Fz and Pz respectively). Further, the late component at Pz was correlated with estab-
lished measures of disease progression such as CAG repeats and DBS, supporting a link
between aberrant motor processing and clinical degeneration. Consistent with our hypothesis,
results indicated group differences between pre-HD and controls for premotor, but not motor
measures. No behavioural variable (i.e., reaction time or tapping variability) or electrophysio-
logical activity at time of response (i.e., RP) significantly differentiated pre-HD from controls,
suggesting equivalent performance across groups. Importantly, premotor electrophysiological
activity (the CNV) significantly differentiated pre-HD from controls, with more widespread
electrical activation (Fz, Cz, Pz) and early and elevated preparatory motor activity. Aberrant
electrical activity was further suggested by exploratory scalp topography, with partial lateralisa-
tion in pre-HD, but not control or symp-HD groups, across the CNV periods. Activation
across frontal and parietal regions in pre-HD may suggest a shift in cortical motor control
Table 2. Electrophysiological and behavioural results for participants in the Tapping Task 1 (cued and self-paced Conditions). Amplitude and
latency by at Cz, averaged across groups. Standard deviations (SD) provided in parentheses.
Controls(n = 17) Pre-HD(n = 17) Symp-HD(n = 10)
Behavioural (Tapping)
Time between taps
Cued 4.47 (.035) 4.42 (.058) 4.53 (.080)
Self-paced 4.12 (.118) 4.08 (.147) 4.17 (.359)
Variability
Cued .20 (.015) .28 (.036) .47 (.091)a**b*
Self-paced .67 (.108) .69 (.125) 1.45 (.249)a**b**
Electrophysiological (Amplitude/Latency)
Cued
Peak Amplitude -6.128 (6.57) -5.255 (4.73) -2.866 (7.96)
Relative Amplitude -9.118 (4.22) -7.483 (3.53) -4.016 (1.91) a**b**
Relative Latency -164.23 (70.51) -193.41 (59.24) -190.80 (81.37)
Self-paced
Peak Amplitude -8.615 (5.47) -7.132 (5.94) -5.638 (8.74)
Relative Amplitude -10.28 (4.95) -7.883 (2.81) -4.961 (2.70) a**b**
Relative Latency -158.11 (52.19) -174.94 (55.48) -226.40 (63.43)
Relative amplitude and latency are computed based on the difference in peak values between the negative peak occurring -50 to 100ms prior to the motor
response, and the positive peak 100 to 300 ms post response. Peak amplitude represents the negative peak occurring around time of response (-150 to
200 ms). Independent samples t-tests used for differences between groups,
* p < .05,
** p < .01.
a significantly different from controls,
b significantly different from pre-HD.
doi:10.1371/journal.pone.0138563.t002
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away from primary and secondary motor areas. As there was no performance impairment, we
argue that this increased activation may facilitate neural compensation, allowing cognitively
intact pre-HD individuals to offset dysfunction [3–5, 11–14].
The RP, a well-established measure of motor activity, began approximately 2 seconds prior
to the finger tap, occurring maximally at the vertex (Cz), and was largest in self-paced finger
taps, within each group. We used peak-to-peak values to represent the difference in processing
between the pre-movement negative peak, and the positive peak occurring after movement.
Symp-HD significantly differed from controls and pre-HD groups in relative amplitude of the
component, generating motor potentials which were smaller in amplitude in response to the
button press. Relative latency also approached significance, with symp-HD responses longer
than those of controls, particularly during self-paced tapping. As expected, the RP in pre-HDs
did not differ significantly from controls or symp-HD groups. Disruption of the RP in symp-
HD, but not pre-HD stages, is an important finding and may reflect increased inefficiency of
the motor cortex with more time required to reach maximum amplitudes (which are signifi-
cantly smaller than controls). Accordingly, this finding was accompanied by significantly
Table 3. Electrophysiological and behavioural results for participants in the Sensorimotor Integration Task 2. Amplitudes of early and late CNV by
group at Fz, Cz, and Pz. Standard deviations (SD) provided in parenthesis.
Control(n = 17) Pre-HD(n = 19) Symp-HD(n = 12)
Behavioural (Tapping)
Reaction Time (ms) 750.97 (203.08) 779.11 (243.62) 1306.66 (324.12)a**b**
Electrophysiological (Peak Amplitude/Area)
Fz
Peak Early CNV -4.14 (2.85) -6.43 (7.49) -.231 (3.65)
Peak Late CNV -5.49 (4.94) -5.35 (3.42) -.034 (4.90)ab*
Peak Difference 1.35 (3.53) -1.07 (5.87) -.197 (3.21)
Area Early CNV -1.87 (3.06) -3.39 (5.13) 1.79 (3.09)
Area Late CNV -3.89 (4.26) -3.27 (2.77) 1.61 (5.15)ab*
Cz
Peak Early CNV -3.55 (3.32) -7.23 (6.37) -.67 (3.65)b*
Peak Late CNV -8.70 (4.14) -7.75 (4.81) -3.68 (6.43)
Peak Difference 5.15 (4.04) .51 (5.47)a* 3.00 (4.49)
Area Early CNV -.946 (3.27) -4.21 (5.03) 2.03 (2.99)b*
Area Late CNV -6.79 (3.59) -5.93 (4.56) -1.73 (6.07)
Pz
Peak Early CNV -2.31 (2.90) -5.08 (4.76) -.163 (4.81)b*
Peak Late CNV -6.83 (4.21) -6.99 (5.49) -1.80 (5.21)b*
Peak Difference 4.53 (4.29) 1.91 (5.07) 1.64 (4.34)
Area Early CNV .419 (2.77) -2.30 (4.05) 2.96 (3.80)b*
Area Late CNV -4.94 (4.03) -5.60 (6.69) -.066 (4.94)
‘Peak amplitude’ refers to the maximum negative value in micro volts obtained within the early CNV or late CNV period, with early CNV defined as the
period 550–750 ms following stimulus 1, and late CNV defined as the period in the 200 ms prior to stimulus 2. Area refers to the mean amplitude in micro
volts during each respective CNV period, obtained separately for each electrode site, and is included to support peak amplitude. Independent samples t-
tests used for differences between groups,
* p < .05,
** p < .01.
a significantly different from controls,
b significantly different from pre-HD.
doi:10.1371/journal.pone.0138563.t003
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slower reaction times in symp-HD. Accordingly, this finding was accompanied by significantly
slower reaction times in symp-HD, but not response inhibition inaccuracy (No-Go errors).
Breakdown of response inhibition has previously been found in symp and pre-HD [35–36].
The contrary findings to previous studies may be due to differences in our task parameters (e.g.
cue prior to Go/No-Go stimuli, no timing feedback), which may interact with these complex
processes to suggest maintained response inhibition accuracy in HD despite impairment. How-
ever, if response inhibition is intact, but reaction time impaired, this could suggest that costs of
maintaining accuracy are also be reflected in inefficient processing of the RP. Inefficient and
inaccurate motor execution in symp-HD has been previously suggested by abnormal force,
precision, range and velocity during motor tasks [37–38]. The degree of structural
Fig 1. Tapping Task 1 (cued and self-paced Conditions).Grand average Readiness Potential (RP) waveforms are shown at Cz for each of the control,
pre-HD and symp-HD groups. (A) cued tapping. (B) Self-paced tapping. Time ‘0’ represents the time of motor response (right index finger button press).
doi:10.1371/journal.pone.0138563.g001
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degeneration in symp-HDmay lead to an inability to recruit additional brain regions as part of
a compensation process [14]. Regulation of the motor response itself may be impaired, as
symp-HD have shown reduced ipsilateral inhibition and secondary, contralateral activation
following normal contralateral MRP activation during a choice reaction task [12]. This could
also be related to disruption of hemispheric communication of the basal ganglia; for example,
individuals with unilateral basal ganglia lesions demonstrate RPs with a reduced gradient in
ipsilateral and contralateral hemispheres following wrist flexion with bilateral presentation
[39]. Compensation likely occurs across modalities; recruitment of additional brain regions in
maintenance of performance has been previously identified in working memory, with
increased, differential prefrontal activation identified in pre-HD in absence of performance
detriment [16, 40]. The intactness of the neural motor response in pre-HD, coupled with no
difference in reaction times compared with controls, support a likely functional compromise.
For the premotor component (CNV), symp-HD demonstrated significantly smaller peak
amplitudes at Cz and Pz compared to the pre-HD group; however, there were no significant
Fig 2. Sensorimotor Integration Task/CNV.Grand average Go/No-Go waveforms at Fz, Cz and Pz across subjects; S1 and S2 are the warning and
stimulus onset times respectively. Scalp topography maps represent mean amplitude of the CNV at early and late periods by group. Early CNV refers to the
period 550–750 ms following presentation of the warning light (stimulus 1); Late CNV refers to the period 200 ms prior to the onset of the Go/No-Go cue for
button press (stimulus 2).
doi:10.1371/journal.pone.0138563.g002
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differences in the early CNV at Cz between symp-HD and controls. This result is in contrast to
Tommaso and colleagues [31], who suggested that early CNV impairment represents an atten-
tional impairment prior to execution of the motor response in symp-HD. We argue against
this theory as symp-HD showed no significant difference in number of correct/incorrect
responses during Go/No-Go (Task 2) performance, despite significantly slower reaction times.
In the late CNV component, symp-HD had significantly reduced peak amplitude at Fz, com-
pared with pre-HD and control groups. Peak amplitude at Pz was also significantly reduced in
symp-HD, compared to pre-HD, and positively correlated with CAG repeats and DBS in
symp-HD. Tommaso and colleagues [28] found no differences in late CNV, and proposed that
this component may become reduced in later stages of the disease. This is plausible given that
the prior study had an average illness duration of 2.9 years compared to an estimate of 4.1
years (sample sizes equal; SD = 12.96) in the present study. Reduced late CNV has been previ-
ously found in Parkinson’s disease and has been associated with dysfunction in the basal gan-
glia and associated thalamo-cortical circuitry [24], and later in HD as a consequence of further
degeneration. Moreover, in symp-HD peak amplitudes of late CNV at Pz were correlated with
DBS and CAG repeats, at Fz with UHDRS motor score in, and in pre-HD Cz correlated with
CAG repeats. The positive correlations may indicate a link between atypical network recruit-
ment and progressing disease pathology. In both the early and late CNV, exploratory scalp
topography suggested positive and aberrant activation in symp-HD, which may support
increasing inefficiency of the motor system due to degeneration. However, considerable vari-
ance was apparent and likely reflects individual differences in disease progression, duration,
and cognitive reserve.
The CNV waveform typically appears as a negative, slow rise slope [24]. Unlike that of con-
trols, the waveform of the pre-HD CNV was not maximal at Cz. Intriguingly, the waveform for
pre-HD was higher in amplitude and flattened relative to controls and symp-HD, suggesting
early, uniform activation, occurring consistently throughout the preparatory period between
the two contingent stimuli. This difference between early and late CNV was significant only for
pre-HD. The consistency of this waveform across Fz and Pz suggest a shift in cortical motor
control involving the recruitment of additional brain regions. This may be reflected in scalp
topography; lateralised activation was evident in both early and late CNVmaps for pre-HD.
Although not significant, the waveform difference at Cz trended towards significance in symp-
HD, producing considerably flatter CNV profiles than control counterparts. This likely reflects
more significant and widespread neural dysfunction, which restricts resources and cognitive
reserve which could otherwise enable task performance in the context of degeneration. Thus,
CNV may represent a sensitive measure of disease progression in pre-HD.
There are a few limitations of the study: the symp-HD group was not age-matched to
healthy controls, and were significantly older and more male predominant than controls, as
well as displaying more executive dysfunction. However, such findings are typical in a symp-
HD group, and we controlled for these factors by including age and gender as covariates.
Unfortunately, it is not practicable to partial out the effect of executive dysfunction. As men-
tioned, considerable variability was evident across individuals within groups in the RP and
CNV results (i.e. within pre-HD).
There were also clear differences in the CNV profile between both the early and late peaks
for individuals. The decision to include peak to peak values was made after viewing the individ-
ual ERPs, not the group averages. When we viewed the group averages our decision was sup-
ported; it became evident that simply using measures of peak amplitude could not possibly
capture group differences due to variability and the influence of other factors (such as motiva-
tion) on amplitude measures. When examining the CNV profile (Fig 2), it is clear that a mea-
sure of amplitude for early and late CNV would not distinguish pre-HD from healthy controls,
Motor Compensation in Huntington’s Disease
PLOS ONE | DOI:10.1371/journal.pone.0138563 September 25, 2015 11 / 14
despite clear differences in the profile of activation. We included peak to peak as a value to bet-
ter capture the degree of activation across the potential, and efficiency of the premotor and
motor systems in preparing for the task.
In summary, this study replicated previous findings of no significant behavioural differences
during motor task performance in pre-HD compared with controls [10, 13, 41–42]. Impor-
tantly, we identified irregular premotor processing (CNV) in pre-HD, which involved more
widespread activation during sensorimotor integration, despite intact motor processing (RP).
This may support theory that during the early premanifest stages the brain may undergo a pro-
cess of maintenance of cortical motor control, which involves recruitment of additional brain
regions and networks to preserve function. Such compensatory mechanisms appear to be more
heavily recruited during more cognitively demanding tasks. Performance intactness in the
pre-HD group suggests compensation may be a reciprocal feedback process, employed to
counterbalance dysfunction in response to unique processing demands. Overall, recruitment of
ancillary circuitry in preservation of motor functions may represent a sensitive functional bio-
marker of disease progression in HD. Future studies in this area using techniques such as func-
tional MRI, magnetoencephalography or standardized low resolution brain electromagnetic
tomography may be able to further elucidate functional connectivity during neural premotor
processing, such as the contributions of neostriatal networks.
Acknowledgments
All authors have no bio-medical, financial interests, or potential conflicts of interests to dis-
close. There were no funding sources for this study.
Author Contributions
Conceived and designed the experiments: NGK RC. Analyzed the data: LMT. Contributed
reagents/materials/analysis tools: LMT RC AC DA NGK. Wrote the paper: LMT. Cleaned and
analysed the data: LMT. Assistance in data analysis: DA RC. Design of statistical analysis: LMT
RC. Clinical testing: AC. Clinical expertise: AC JL. Monitored data collection: NGK RC.
Revised the draft paper: LMT RC JL DA NGK.
References
1. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide
repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993; 72:971–83.
PMID: 8458085
2. Aylward EH, Liu D, Nopoulos PC, Ross CA, Pierson RK, Mills JA, et al. Striatal volume contributes to
the prediction of onset of Huntington disease in incident cases. Biol Psychiatry. 2012; 71:822–8. doi:
10.1016/j.biopsych.2011.07.030 PMID: 21907324
3. Domínguez D JF, Egan GF, Gray MA, Poudel GR, Churchyard A, Chua P, et al. Multi-modal neuroim-
aging in premanifest and early Huntington’s disease: 18 month longitudinal data from the IMAGE-HD
study. PLoS One. 2013; 8:1–10.
4. Georgiou-Karistianis N, Gray MA, Domínguez D JF, Dymowski AR, Bohanna I, Johnston LA, et al.
Automated differentiation of pre-diagnosis Huntington’s disease from healthy control individuals based
on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study. Neurobiol Dis. 2013;
51:82–92. PMID: 23069680
5. Georgiou-Karistianis N, Poudel GR, Domínguez D JF, Langmaid R, Gray MA, Churchyard A, et al.
Functional and connectivity changes during working memory in Huntington's disease: 18 month longitu-
dinal data from the IMAGE-HD study. Brain Cogn. 2013; 83:80–91. doi: 10.1016/j.bandc.2013.07.004
PMID: 23938592
6. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Crayfurd D, et al. Biological and clinical mani-
festations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of
baseline data. Lancet Neurol. 2009; 8:791–801. doi: 10.1016/S1474-4422(09)70170-X PMID:
19646924
Motor Compensation in Huntington’s Disease
PLOS ONE | DOI:10.1371/journal.pone.0138563 September 25, 2015 12 / 14
7. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in
premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal
analysis. Lancet Neurol. 2011; 10:31–42. doi: 10.1016/S1474-4422(10)70276-3 PMID: 21130037
8. Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, et al. Predictors of phenotypic progression
and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analy-
sis of 36-month observational data. Lancet Neurol. 2013; 12: 637–49. doi: 10.1016/S1474-4422(13)
70088-7 PMID: 23664844
9. Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, et al. Neurocognitive signs
in prodromal Huntington disease. Neuropsychol. 2011; 25:1–14.
10. FarrowM, Chua P, Churchyard A, Bradshaw JL, Chiu E, Georgiou-Karistianis N. Proximity to clinical
onset influences motor and cognitive performance in presymptomatic Huntington disease gene carri-
ers. Cogn Behav Neurol. 2006; 19:208–16. PMID: 17159618
11. Beste C, Saft C, Yordanova J, Andrich J, Gold R, Falkenstein M, et al. Functional compensation or
pathology in cortico-subcortical interactions in preclinical Huntington’s disease? Neuropsychologia.
2007; 45:2922–30. PMID: 17692347
12. Beste C, Konrad C, Saft C, Ukas T, Andrich J, Pfleiderer B, et al. Alterations in voluntary movement
execution in Huntington’s disease are related to the dominant motor system—evidence from event-
related potentials. Exp Neurol. 2009; 216:148–57. doi: 10.1016/j.expneurol.2008.11.018 PMID:
19111540
13. Klöppel S, Draganski B, Siebner HR, Tabrizi SJ, Weiller C, Frackowiak RS. Functional compensation
of motor function in pre-symptomatic Huntington’s disease. Brain. 2009; 132:1624–32. doi: 10.1093/
brain/awp081 PMID: 19369489
14. Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC. The cognitive burden in Huntington’s disease: pathol-
ogy, phenotype, and mechanisms of compensation. Mov Disord. 2014; 29:673–83. doi: 10.1002/mds.
25864 PMID: 24757115
15. Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature.
2006; 443:768–73. PMID: 17051202
16. Poudel G, Egan GF, Churchyard AJ, Chua P, Stout JC, Georgiou-Karistianis N. Abnormal synchrony of
resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study. J
Psychiatry Neurosci. 2014; 39:87–96. PMID: 24083458
17. Poudel G, Stout JC, Dominguez JF, Gray MA, Salmon L, Churchyard A, et al. Functional changes dur-
ing working memory in Huntington’s disease: 30-month longitudinal data from the IMAGE-HD study.
Brain Struct Funct. 2014; 220:501–12.
18. Georgiou-Karistianis N, Stout JC, Domínguez JF, Carron SP, Ando A, Churchyard A, et al. Functional
magnetic resonance imaging of working memory in Huntington’s disease: cross-sectional data from the
IMAGE-HD study. Hum Brain Mapp. 2014; 35:1847–64. doi: 10.1002/hbm.22296 PMID: 23913754
19. Unschuld PG, Joel SE, Liu X, ShanahanM, Margolis RL, Biglan KM, et al. Impaired cortico-striatal func-
tional connectivity in prodromal Huntington’s disease. Neurosci Lett. 2012; 514:204–9. doi: 10.1016/j.
neulet.2012.02.095 PMID: 22425717
20. Bartenstein P, Weindl A, Spiegel S, Boecker H, Wenzel R, Ceballos-Baumann AO, et al. Central motor
processing in Huntington’s disease. A PET study. Brain. 1997; 120:1553–67. PMID: 9313639
21. Weeks RA, Ceballos-Baumann A, Piccini P. Cortical control of movement in Huntington’s disease. A
PET study. Brain. 1997; 120:1569–78. PMID: 9313640
22. Gavazzi C, Nave RD, Petralli R, Rocca MA, Guerrini L, Tessa C, et al. Combing functional and struc-
tural brain magnetic resonance imaging in Huntington disease. J Comput Assist Tomogr. 2007;
31:574–80. PMID: 17882035
23. Feigin A, Ghilardi MF, Huang C, Ma Y, Carbon M, Guttman M, et al. Preclinical Huntington’s disease:
compensatory brain responses during learning. Ann Neurol. 2005; 59:53–9.
24. Ikeda A, Shibasaki H, Kaji R, Terada K, Nagamine T, Honda M, et al. Dissociation between contingent
negative variation (CNV) and Bereitschaftspotential (BP) in patients with parkinsonism. Electroence-
phalogr Clin Neurophysiol. 1997; 102:142–51. PMID: 9060866
25. Cunnington R, Iansek R, Bradshaw JL. Movement-related potentials in Parkinson’s disease: external
cues and attentional strategies. Mov Disord. 1999; 14:63–8. PMID: 9918346
26. Johnson KA, Cunnington R, Iansek R, Bradshaw JL, Georgiou N, Chiu E. Movement-related potentials
in Huntington's disease: movement preparation and execution. Exp Brain Res. 2001; 238:492–9.
27. Johnson KA, Cunnington R, Bradshaw JL, Chiu, Iansek R. Effect of an attentional strategy on move-
ment-related potentials recorded from subjects with Huntington's disease. Mov Disord. 2002; 17:998–
1003. PMID: 12360549
Motor Compensation in Huntington’s Disease
PLOS ONE | DOI:10.1371/journal.pone.0138563 September 25, 2015 13 / 14
28. de TommasoM, Difruscolo O, Sciruicchio V, Specchio N, Livrea P. Abnormalities of the contingent neg-
ative variation in Huntington's disease: correlations with clinical features. J Neurol Sci. 2007; 254:84–9.
PMID: 17300807
29. Huntington Study Group. The Unified Huntington’s Disease Rating Scale: reliability and consistency.
Mov Disord. 1996; 11:136–42. PMID: 8684382
30. Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM. Motor timing variability
increases in preclinical Huntington's disease patients as estimated onset of motor symptoms
approaches. J Int Neuropsychol Soc. 2007; 13:539–43. PMID: 17445303
31. Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin
Neuropsychol. 2004; 19:203–14. PMID: 15010086
32. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent
forms. The Clin Neuropsychol. 1992; 5:125–42.
33. Beck AT, Steer RA, Brown GK. Manual for the Beck Depressive Inventory. 2nd ed. San Antonio, TX:
Psychological Corporation; 1996.
34. Croft RJ, Barry RJ. EOG correction of blinks with saccade coefficients: a test and revision of the
aligned-artefact average solution. Clin Neurophysiol. 2000; 111:444–51. PMID: 10699405
35. Beste C, Saft C, Andrich J, Gold R, Falkenstein M. Response inhibition in Huntington’s disease—A
study using ERPs and sLORETA. Neuropsychologia. 2008; 46:1290–1297. doi: 10.1016/j.
neuropsychologia.2007.12.008 PMID: 18241897
36. Beste C, Ness V, Falkenstein M, Saft C. On the role of fronto-striatal neural synchronization processes
for response inhibition—Evidence from ERP phase-synchronization analyses in pre-manifest Hunting-
ton’s disease gene mutation carriers. Neuropsychologia. 2011; 49:3484–3493. doi: 10.1016/j.
neuropsychologia.2011.08.024 PMID: 21906607
37. Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in
Huntington's Disease. Exp Neurol. 2000; 163:136–48. PMID: 10785452
38. Quinn L, Reilmann R, Marder K, Gordon AM. Altered movement trajectories and force control during
object transport in Huntington's disease. Mov Disord. 2001; 16:469–80. PMID: 11391741
39. Fève A, Bathien N, Rondot P. Abnormal movement related potentials in patients with lesions of basal
ganglia and anterior thalamus. J Neurol Neurosurg Psychiatr. 1994; 57:100–4. PMID: 8301287
40. Wolf RC, Sambataro F, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer B. Aberrant connec-
tivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol. 2008;
213:137–44. doi: 10.1016/j.expneurol.2008.05.017 PMID: 18588876
41. Campodonico JR, Codori AM, Brandt J. Neuropsychological stability over two years in asymptomatic
carriers of the Huntington’s disease mutation. J Neurol Neurosurg Psychiatr. 1996; 61:621–4. PMID:
8971112
42. Giordani B, Berent S, Boivin MJ, Penney JB, Lehtinen S, Markel DS, et al. Longitudinal neuropsycho-
logical and genetic linkage analysis of persons at risk for Huntington’s disease. Arch. Neurol. 1995;
52:59–64. PMID: 7826277
Motor Compensation in Huntington’s Disease
PLOS ONE | DOI:10.1371/journal.pone.0138563 September 25, 2015 14 / 14
